It has been shown that in three brain regions of AD patients there is a reduction in MAPT expression [43], however for PD it has been proposed that brain regions expressing greater levels of MAPT are more susceptible to tau mediated neurodegeneration [44]. The gene discussed is MAPT; the disease is Parkinson disease.